Kinesiophobia, Fear of Falling, Functional Independence, and Psychological Status in Spinal Cord Injury

The Relationship Between Kinesiophobia and Fear of Falling, Functional Independence, and Psychological Status in Individuals With Paraplegic Spinal Cord Injury: A Cross-Sectional Study

Individuals aged 18-65 years who have been clinically diagnosed with spinal cord injury and have developed paraplegia will be included in the study. Demographic and clinical data of the participants, including age, sex, height, weight, etiology of injury, level of injury, duration of injury, and comorbidities, will be recorded. In addition, disease-specific characteristics such as ambulation status, wheelchair use, presence of incontinence, and presence and severity of pain will be assessed.

Kinesiophobia levels of the patients will be evaluated using the Tampa Scale for Kinesiophobia (TSK). Functional independence will be assessed using the Spinal Cord Independence Measure-III Self-Report (SCIM-III SR). Fall-related concerns will be evaluated using the Spinal Cord Injury-Falls Concern Scale (SCI-FCS). Pain severity will be assessed using the Visual Analog Scale (VAS), and the presence of neuropathic pain will be evaluated using the DN4 Neuropathic Pain Questionnaire.

Symptoms related to anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS). All assessments will be conducted through face-to-face interviews. The collected data will be analyzed to investigate the relationship between kinesiophobia and functional independence, fear of falling, pain, and psychological status in individuals with paraplegic spinal cord injury. Validated Turkish versions of all scales used in the study will be employed.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

70

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Spinal cord injury patients

Description

Inclusion Criteria:

  • Aged between 18 and 65 years
  • Clinically diagnosed with spinal cord injury
  • Presence of paraplegia
  • Injury duration of at least 3 months (to exclude acute phase effects)
  • Medically stable condition
  • Ability to understand and respond to questionnaires
  • Willingness to participate and provide written informed consent

Exclusion Criteria:

  • Tetraplegia or other neurological conditions affecting motor function
  • Severe cognitive impairment or psychiatric disorders that may interfere with assessments
  • Presence of active infection, malignancy, or severe systemic disease
  • Severe visual or hearing impairment preventing participation in assessments
  • Current participation in another interventional clinical study
  • Recent surgery or acute medical condition within the last 3 months
  • Incomplete clinical data or inability to complete questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tampa Scale for Kinesiophobia (TSK)
Time Frame: Baseline
The TSK is a self-reported questionnaire used to assess fear of movement/re-injury. It consists of 17 items scored on a 4-point Likert scale, with total scores ranging from 17 to 68. Higher scores indicate greater kinesiophobia.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal Cord Independence Measure-III Self-Report (SCIM-III SR)
Time Frame: Baseline
The SCIM-III SR evaluates functional independence in individuals with spinal cord injury. It includes domains such as self-care, respiration and sphincter management, and mobility. Total scores range from 0 to 100, with higher scores indicating greater independence.
Baseline
Spinal Cord Injury-Falls Concern Scale (SCI-FCS)
Time Frame: Baseline
The SCI-FCS assesses concerns about falling during daily activities in individuals with spinal cord injury. Higher scores indicate greater fear of falling.
Baseline
Visual Analog Scale (VAS)
Time Frame: Baseline
Pain intensity is measured using a 10-cm visual analog scale, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Baseline
DN4 Neuropathic Pain Questionnaire
Time Frame: Baseline
The DN4 questionnaire is used to identify neuropathic pain. A score of ≥4 suggests the presence of neuropathic pain.
Baseline
Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)
Time Frame: Baseline
The HADS-A subscale consists of 7 items assessing anxiety symptoms. Scores range from 0 to 21, with higher scores indicating greater anxiety levels.
Baseline
Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)
Time Frame: Baseline
The HADS-D subscale consists of 7 items assessing depressive symptoms. Scores range from 0 to 21, with higher scores indicating greater depression levels.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 20, 2026

Primary Completion (Estimated)

June 20, 2026

Study Completion (Estimated)

June 20, 2026

Study Registration Dates

First Submitted

April 18, 2026

First Submitted That Met QC Criteria

April 18, 2026

First Posted (Actual)

April 24, 2026

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 18, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe